Harding Loevner’s Merck MRK Stock Holding History

Harding Loevner’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-734	Closed	-$63K	–	132
2022 Q3	$63K	Hold	734	–	–	﹤0.01%	95
2022 Q2	$67K	Hold	734	–	–	﹤0.01%	94
2022 Q1	$64K	Hold	734	–	–	﹤0.01%	93
2021 Q4	$56K	Hold	734	–	–	﹤0.01%	109
2021 Q3	$55K	Hold	734	–	–	﹤0.01%	98
2021 Q2	$57K	Sell	734 -35	-5%	-$2.6K	﹤0.01%	103
2021 Q1	$57K	Hold	769	–	–	﹤0.01%	108
2020 Q4	$60K	Hold	769	–	–	﹤0.01%	100
2020 Q3	$61K	Hold	769	–	–	﹤0.01%	131
2020 Q2	$57K	Sell	769 -153	-17%	-$11.5K	﹤0.01%	102
2020 Q1	$68K	Hold	922	–	–	﹤0.01%	97
2019 Q4	$80K	Hold	922	–	–	﹤0.01%	94
2019 Q3	$74K	Hold	922	–	–	﹤0.01%	88
2019 Q2	$74K	Hold	922	–	–	﹤0.01%	95
2019 Q1	$73K	Hold	922	–	–	﹤0.01%	88
2018 Q4	$67K	Buy	+922	New	+$65.1K	﹤0.01%	88

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Harding Loevner's MRK Position: Q4 2022 in Review

Harding Loevner sold out of Merck (MRK) in Q4 2022, closing a stake of 734 shares — an estimated $63K sold.

Harding Loevner first reported a position in MRK in Q4 2018 and held it in 16 quarters. The position peaked at $80K in Q4 2019. 3,238 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

Harding Loevner reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
Harding Loevner sold 734 Merck shares in Q4 2022, an estimated $63K.
Harding Loevner first reported a position in Merck in Q4 2018 and held it in 16 quarters.
Harding Loevner's Merck position peaked at $80K in Q4 2019.
3,238 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Harding Loevner's 13F filing for Q4 2022, filed 14 Feb 2023.